No Data
On January 9, Gushengtang (02273.HK) spent HKD 3.99 million to repurchase 0.143 million shares.
Gelonghui, January 9 – Gushengtang (02273.HK) announced that on January 9, it spent 3.99 million Hong Kong dollars to repurchase 0.143 million shares.
The construction of specialized traditional Chinese medicine departments is accelerating, and TCM clinical services maintain high prosperity.
Golden Owl Financial News | According to recent reports from CCTV News on the National Administration of Traditional Chinese Medicine, through a series of measures such as accelerating the construction of Traditional Chinese Medicine advantageous specialties, the high-quality development of county-level Traditional Chinese Medicine Hospitals, and the construction of collaborative hospitals for Chinese and Western medicine, China has now established 1,158 national advantageous specialties in Traditional Chinese Medicine. The next step will be to build a network of advantageous specialties in Traditional Chinese Medicine and create clusters of advantageous specialties, focusing on strengthening the construction of pediatrics, geriatrics, and mental illness specialties, as well as promoting the foundation and quality of county-level Traditional Chinese Medicine hospitals and enhancing grassroots Traditional Chinese Medicine service capabilities. Under the dual drive of policy and clinical demand, the Traditional
GTJA: The centralized procurement of Chinese Patent Medicine is still in the early stages, and quality improvement and expansion are expected to continue to progress.
GTJA released a Research Report stating that the bidding for the third batch of national Chinese Patent Medicine centralized procurement has opened, with the reduction slightly exceeding expectations.
China Healthcare Sector to Get Policy Boost in 1Q -- Market Talk
The seasonal influenza A has entered the epidemic period, and the sales of related Chinese Patent Medicine products have significantly increased.
① Recently, the positive rate of influenza virus has significantly increased, with over 99% being type A influenza. Market data shows a clear increase in the demand for various Traditional Chinese Medicine cold medicine products. ② Today, stock prices of several listed companies in the Traditional Chinese Medicine Industry, such as Shanxi Zhendong Pharmaceutical, Hainan Huluwa Pharmaceutical Group, and Zhongsheng Pharmaceutical, have reached the daily limit, with the Traditional Chinese Medicine Sector overall rising, and the Traditional Chinese Medicine 50 ETF increasing by 3.21%.
Guoshengtang (02273.HK) spent HKD 17.43 million to repurchase 0.615 million shares on January 6.
Gelonghui reported on January 6 that Guishengtang (02273.HK) announced it spent 17.43 million HKD to repurchase 0.615 million shares on January 6.
Investors Give Zhejiang Crystal-Optech Co., Ltd (SZSE:002273) Shares A 27% Hiding
